Creative Planning
BXRX

Creative Planning’s Baudax Bio, Inc. Common Stock BXRX Stock Holding History

Creative Planning’s Portfolio BXRX Stock Details BXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-45,001
Closed -$52.7K – 3101
2023
Q2 		$52.7K Buy
+45,001
New +$43K ﹤0.01% 2435
2020
Q4 		– Sell
-19
Closed -$75K – 2504
2020
Q3 		$75K Buy
19
+1
+6% +$4.53K ﹤0.01% 1866
2020
Q2 		$104K Buy
+18
New +$86.4K ﹤0.01% 1657

Other funds holding BXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Creative Planning's BXRX Position: Q3 2023 in Review

Creative Planning sold out of Baudax Bio, Inc. Common Stock (BXRX) in Q3 2023, closing a stake of 45,001 shares — an estimated $52.7K sold.

Creative Planning first reported a position in BXRX in Q2 2020 and held it in 3 quarters. The position peaked at $104K in Q2 2020. 15 funds tracked by Wall St. Rank hold BXRX as of Q3 2023.

  • Creative Planning reported no remaining Baudax Bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Creative Planning sold 45,001 Baudax Bio, Inc. Common Stock shares in Q3 2023, an estimated $52.7K.
  • Creative Planning first reported a position in Baudax Bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Creative Planning's Baudax Bio, Inc. Common Stock position peaked at $104K in Q2 2020.
  • 15 funds tracked by Wall St. Rank held Baudax Bio, Inc. Common Stock as of Q3 2023.

Based on Creative Planning's 13F filing for Q3 2023, filed 16 Nov 2023.